TrialCirculation2026

Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial.

Marianna Fontana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.